Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1965557rdf:typepubmed:Citationlld:pubmed
pubmed-article:1965557lifeskim:mentionsumls-concept:C0015967lld:lifeskim
pubmed-article:1965557lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:1965557lifeskim:mentionsumls-concept:C2239176lld:lifeskim
pubmed-article:1965557lifeskim:mentionsumls-concept:C0027396lld:lifeskim
pubmed-article:1965557lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:1965557lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:1965557lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:1965557lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:1965557lifeskim:mentionsumls-concept:C1332335lld:lifeskim
pubmed-article:1965557lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:1965557pubmed:issue6lld:pubmed
pubmed-article:1965557pubmed:dateCreated1991-6-26lld:pubmed
pubmed-article:1965557pubmed:abstractTextGood antipyretic response was obtained when naproxen was given at 600 mg/day for about one week to patients who developed fever after transcatheter arterial embolization (TAE). Fever recurred in several patients, but subsided again when naproxen was given at 300 mg/day. No patients developed gastric mucosal lesions of clinical concern that seemed to be related to naproxen.lld:pubmed
pubmed-article:1965557pubmed:languageenglld:pubmed
pubmed-article:1965557pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1965557pubmed:citationSubsetIMlld:pubmed
pubmed-article:1965557pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1965557pubmed:statusMEDLINElld:pubmed
pubmed-article:1965557pubmed:issn0288-2043lld:pubmed
pubmed-article:1965557pubmed:authorpubmed-author:NakamuraHHlld:pubmed
pubmed-article:1965557pubmed:authorpubmed-author:InoueKKlld:pubmed
pubmed-article:1965557pubmed:authorpubmed-author:HirotaNNlld:pubmed
pubmed-article:1965557pubmed:authorpubmed-author:AkajiHHlld:pubmed
pubmed-article:1965557pubmed:authorpubmed-author:HaginoMMlld:pubmed
pubmed-article:1965557pubmed:issnTypePrintlld:pubmed
pubmed-article:1965557pubmed:volume8lld:pubmed
pubmed-article:1965557pubmed:ownerNLMlld:pubmed
pubmed-article:1965557pubmed:authorsCompleteYlld:pubmed
pubmed-article:1965557pubmed:pagination227-9lld:pubmed
pubmed-article:1965557pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1965557pubmed:meshHeadingpubmed-meshheading:1965557-...lld:pubmed
pubmed-article:1965557pubmed:meshHeadingpubmed-meshheading:1965557-...lld:pubmed
pubmed-article:1965557pubmed:meshHeadingpubmed-meshheading:1965557-...lld:pubmed
pubmed-article:1965557pubmed:meshHeadingpubmed-meshheading:1965557-...lld:pubmed
pubmed-article:1965557pubmed:meshHeadingpubmed-meshheading:1965557-...lld:pubmed
pubmed-article:1965557pubmed:meshHeadingpubmed-meshheading:1965557-...lld:pubmed
pubmed-article:1965557pubmed:meshHeadingpubmed-meshheading:1965557-...lld:pubmed
pubmed-article:1965557pubmed:meshHeadingpubmed-meshheading:1965557-...lld:pubmed
pubmed-article:1965557pubmed:articleTitleStudy of response to naproxen in patients with hepatocellular carcinoma who developed fever following transcatheter arterial embolization.lld:pubmed
pubmed-article:1965557pubmed:affiliationDepartment of Internal Medicine, Nishiyodo Hospital, Japan.lld:pubmed
pubmed-article:1965557pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1965557pubmed:publicationTypeCase Reportslld:pubmed